| 50228-523-05 |
50228-523 |
HUMAN PRESCRIPTION DRUG |
gabapentin |
gabapentin |
TABLET |
ORAL |
20250920 |
N/A |
ANDA |
ANDA218491 |
ScieGen Pharmaceuticals, Inc. |
GABAPENTIN |
300 mg/1 |
500 TABLET in 1 BOTTLE (50228-523-05) |
| 50228-523-30 |
50228-523 |
HUMAN PRESCRIPTION DRUG |
gabapentin |
gabapentin |
TABLET |
ORAL |
20250920 |
N/A |
ANDA |
ANDA218491 |
ScieGen Pharmaceuticals, Inc. |
GABAPENTIN |
300 mg/1 |
30 TABLET in 1 BOTTLE (50228-523-30) |
| 50228-523-90 |
50228-523 |
HUMAN PRESCRIPTION DRUG |
gabapentin |
gabapentin |
TABLET |
ORAL |
20250920 |
N/A |
ANDA |
ANDA218491 |
ScieGen Pharmaceuticals, Inc. |
GABAPENTIN |
300 mg/1 |
90 TABLET in 1 BOTTLE (50228-523-90) |
| 50228-524-05 |
50228-524 |
HUMAN PRESCRIPTION DRUG |
gabapentin |
gabapentin |
TABLET |
ORAL |
20250920 |
N/A |
ANDA |
ANDA218491 |
ScieGen Pharmaceuticals, Inc. |
GABAPENTIN |
600 mg/1 |
500 TABLET in 1 BOTTLE (50228-524-05) |
| 50228-524-30 |
50228-524 |
HUMAN PRESCRIPTION DRUG |
gabapentin |
gabapentin |
TABLET |
ORAL |
20250920 |
N/A |
ANDA |
ANDA218491 |
ScieGen Pharmaceuticals, Inc. |
GABAPENTIN |
600 mg/1 |
30 TABLET in 1 BOTTLE (50228-524-30) |
| 50228-524-90 |
50228-524 |
HUMAN PRESCRIPTION DRUG |
gabapentin |
gabapentin |
TABLET |
ORAL |
20250920 |
N/A |
ANDA |
ANDA218491 |
ScieGen Pharmaceuticals, Inc. |
GABAPENTIN |
600 mg/1 |
90 TABLET in 1 BOTTLE (50228-524-90) |